{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T12:23:30Z","timestamp":1787660610201,"version":"build-2736575974"},"reference-count":84,"publisher":"Elsevier BV","issue":"8-9","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Cardiovascular Diseases"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.acvd.2026.04.004","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:04:52Z","timestamp":1778889892000},"page":"604-614","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Thrombophilia testing in venous thromboembolism: When, who and why it matters. A practical review"],"prefix":"10.1016","volume":"119","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5502-542X","authenticated-orcid":false,"given":"Elena-Mihaela","family":"Cordeanu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corina","family":"Mirea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Zamperini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sol\u00e8ne","family":"Brouder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7991-1645","authenticated-orcid":false,"given":"Dominique","family":"Stephan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.acvd.2026.04.004_bib0425","doi-asserted-by":"crossref","first-page":"11447","DOI":"10.3390\/ijms252111447","article-title":"The basic principles of pathophysiology of venous thrombosis","volume":"25","author":"Schulman","year":"2024","journal-title":"IJMS"},{"key":"10.1016\/j.acvd.2026.04.004_bib0430","first-page":"516","article-title":"Inherited antithrombin deficiency causing thrombophilia","volume":"13","author":"Egeberg","year":"1965","journal-title":"Thromb Diath Haemorrh"},{"key":"10.1016\/j.acvd.2026.04.004_bib0435","first-page":"323","article-title":"Republication de\u00a0: Recommandations de bonne pratique pour la prise en charge de la maladie veineuse thromboembolique chez l\u2019adulte. Version courte","volume":"43","author":"Sanchez","year":"2019","journal-title":"Med Nucl"},{"key":"10.1016\/j.acvd.2026.04.004_bib0440","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejvs.2020.09.023","article-title":"Editor's Choice - European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis","volume":"61","author":"Kakkos","year":"2021","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.acvd.2026.04.004_bib0445","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/bjh.18239","article-title":"Thrombophilia testing: a British Society for Haematology guideline","volume":"198","author":"Arachchillage","year":"2022","journal-title":"Br J Haematol"},{"key":"10.1016\/j.acvd.2026.04.004_bib0450","doi-asserted-by":"crossref","first-page":"7101","DOI":"10.1182\/bloodadvances.2023010177","article-title":"American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing","volume":"7","author":"Middeldorp","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.acvd.2026.04.004_bib0455","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1160\/TH15-02-0141","article-title":"Classic thrombophilic gene variants","volume":"114","author":"Mannucci","year":"2015","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.acvd.2026.04.004_bib0460","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/asheducation-2016.1.1","article-title":"Inherited thrombophilia: a double-edged sword","volume":"2016","author":"Middeldorp","year":"2016","journal-title":"Hematol Am Soc Hematol Educ Prog"},{"key":"10.1016\/j.acvd.2026.04.004_bib0465","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1182\/bloodadvances.2024013478","article-title":"Thrombophilia testing: does practice follow guidelines?","volume":"8","author":"Middeldorp","year":"2024","journal-title":"Blood Adv"},{"key":"10.1016\/j.acvd.2026.04.004_bib0470","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s10654-013-9825-8","article-title":"Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls","volume":"28","author":"Simone","year":"2013","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.acvd.2026.04.004_bib0475","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.thromres.2015.03.010","article-title":"Natural anticoagulants deficiency and the risk of venous thromboembolism: a meta-analysis of observational studies","volume":"135","author":"Di Minno","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.acvd.2026.04.004_bib0480","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1055\/s-0038-1625983","article-title":"Risk of venous thrombosis in antithrombin deficiency: a systematic review and bayesian meta-analysis","volume":"44","author":"Croles","year":"2018","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.acvd.2026.04.004_bib0485","doi-asserted-by":"crossref","first-page":"17103","DOI":"10.1038\/nrdp.2017.103","article-title":"Antiphospholipid syndrome","volume":"4","author":"Schreiber","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.acvd.2026.04.004_bib0490","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1136\/ard-2023-224609","article-title":"2023 ACR\/EULAR antiphospholipid syndrome classification criteria","volume":"82","author":"Barbhaiya","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.acvd.2026.04.004_bib0495","doi-asserted-by":"crossref","first-page":"4950","DOI":"10.1182\/bloodadvances.2024012611","article-title":"Venous thromboembolism characteristics and outcomes among RIETE patients tested and untested for inherited thrombophilia","volume":"8","author":"Cohen","year":"2024","journal-title":"Blood Adv"},{"key":"10.1016\/j.acvd.2026.04.004_bib0500","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1056\/NEJMra1700365","article-title":"Thrombophilia testing and venous thrombosis","volume":"377","author":"Connors","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2026.04.004_bib0505","doi-asserted-by":"crossref","first-page":"104247","DOI":"10.1016\/j.lpm.2024.104247","article-title":"Impact of thrombophilia on venous thromboembolism management","volume":"53","author":"Emmerich","year":"2024","journal-title":"Press Med"},{"key":"10.1016\/j.acvd.2026.04.004_bib0510","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.3390\/ijms23031821","article-title":"Inherited thrombophilia in the era of direct oral anticoagulants","volume":"23","author":"Khider","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.acvd.2026.04.004_bib0515","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1161\/CIRCULATIONAHA.109.906347","article-title":"Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and Prothrombin G20210A","volume":"121","author":"Lijfering","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2026.04.004_bib0520","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1016\/j.jtha.2025.07.034","volume":"23","author":"Poli","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.acvd.2026.04.004_bib0525","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1182\/hematology.2024000593","article-title":"Hormone-related thrombosis: duration of anticoagulation, risk of recurrence, and the role of hypercoagulability testing","volume":"2024","author":"Scheres","year":"2024","journal-title":"Hematol Am Soc Hematol Educ Prog"},{"key":"10.1016\/j.acvd.2026.04.004_bib0530","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1111\/j.1538-7836.2008.03055.x","article-title":"Testing for inherited thrombophilia does not reduce the recurrence of venous thrombosis","volume":"6","author":"Coppens","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.acvd.2026.04.004_bib0535","article-title":"Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis","volume":"366","author":"Khan","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.acvd.2026.04.004_bib0540","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1160\/TH08-06-0364","article-title":"High long-term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C or antithrombin","volume":"101","author":"Brouwer J-LP","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.acvd.2026.04.004_bib0545","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/j.1538-7836.2010.03840.x","article-title":"A prospective cohort study on the absolute risks of venous thromboembolism and predictive value of screening asymptomatic relatives of patients with hereditary deficiencies of protein S, protein C or antithrombin","volume":"8","author":"Mahmoodi","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.acvd.2026.04.004_bib0550","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1365-2141.2012.09249.x","article-title":"Guidelines on the investigation and management of venous thrombosis at unusual sites","volume":"159","author":"Tait","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.acvd.2026.04.004_bib0555","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/j.1538-7836.2007.02424.x","article-title":"Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders","volume":"5","author":"De Stefano","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.acvd.2026.04.004_bib0560","first-page":"249","article-title":"Impact of the type of SERPINC1 mutation and subtype of antithrombin deficiency on the thrombotic phenotype in hereditary antithrombin deficiency","volume":"111","author":"Luxembourg","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.acvd.2026.04.004_bib0565","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0140-6736(83)91216-3","article-title":"Inherited protein C deficiency and coumarin-responsive chronic relapsing purpura fulminans in a newborn infant","volume":"2","author":"Branson","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.acvd.2026.04.004_bib0570","doi-asserted-by":"crossref","first-page":"101466","DOI":"10.1016\/j.gim.2025.101466","article-title":"Venous thromboembolism laboratory testing (factor V Leiden and factor II c.*97G>A), 2025 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG)","volume":"27","author":"Kang","year":"2025","journal-title":"Genet Med"},{"key":"10.1016\/j.acvd.2026.04.004_bib0575","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1182\/blood-2012-02-407551","article-title":"Broadening the factor V Leiden paradox: pulmonary embolism and deep-vein thrombosis as 2 sides of the spectrum","volume":"120","author":"Van Langevelde","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.acvd.2026.04.004_bib0580","doi-asserted-by":"crossref","first-page":"5710","DOI":"10.1182\/bloodadvances.2024014252","article-title":"Ancestry-independent risk of venous thromboembolism in individuals with sickle cell trait vs factor V Leiden","volume":"8","author":"Lin","year":"2024","journal-title":"Blood Adv"},{"key":"10.1016\/j.acvd.2026.04.004_bib0585","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3390\/hematolrep17050045","article-title":"Interplay between sickle cell disease and thrombosis: a single center experience of pathophysiology and potential risk factors","volume":"17","author":"Tzanninis","year":"2025","journal-title":"Hematol Rep"},{"key":"10.1016\/j.acvd.2026.04.004_bib0590","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/ajh.27500","article-title":"Hypercoagulability in hemoglobinopathies: decoding the thrombotic threat","volume":"100","author":"Bou-Fakhredin","year":"2025","journal-title":"Am J Hematol"},{"key":"10.1016\/j.acvd.2026.04.004_bib0595","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/ejh.13807","article-title":"Venous thromboembolism prophylaxis in hospitalized sickle cell disease and sickle cell trait patients","volume":"109","author":"Ionescu","year":"2022","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.acvd.2026.04.004_bib0600","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.thromres.2018.07.008","article-title":"The genetics of antithrombin","volume":"169","author":"Corral","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.acvd.2026.04.004_bib0605","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1160\/TH16-08-0635","article-title":"Thrombotic risk according to SERPINC1 genotype in a large cohort of subjects with antithrombin inherited deficiency","volume":"117","author":"Alhenc-Gelas","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.acvd.2026.04.004_bib0610","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1055\/s-0038-1653885","article-title":"Protein C deficiency: a database of mutations, 1995 update. On behalf of the Subcommittee on Plasma Coagulation Inhibitors of the Scientific and Standardization Committee of the ISTH","volume":"73","author":"Reitsma","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.acvd.2026.04.004_bib0615","doi-asserted-by":"crossref","first-page":"e31221","DOI":"10.1097\/MD.0000000000031221","article-title":"Compound heterozygous protein C deficiency with pulmonary embolism caused by a novel PROC gene mutation: case report and literature review","volume":"101","author":"Zhang","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.acvd.2026.04.004_bib0620","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.pathol.2022.09.001","article-title":"A review of laboratory considerations in thrombophilia testing","volume":"54","author":"Ong","year":"2022","journal-title":"Pathology"},{"key":"10.1016\/j.acvd.2026.04.004_bib0625","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1160\/TH07-03-0199","article-title":"Molecular basis of protein S deficiency","volume":"98","author":"Garc\u00eda de Frutos","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.acvd.2026.04.004_bib0630","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1055\/s-0037-1614137","article-title":"Protein S deficiency: a database of mutations--summary of the first update","volume":"84","author":"Gandrille","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.acvd.2026.04.004_bib0635","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1001\/jama.2025.0155","article-title":"Population-scale studies of protein S abnormalities and thrombosis","volume":"333","author":"Chaudhry","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.acvd.2026.04.004_bib0640","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1038\/s41467-018-03911-8","article-title":"Analysis of predicted loss-of-function variants in UK Biobank identifies variants protective for disease","volume":"9","author":"Emdin","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.acvd.2026.04.004_bib0645","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1160\/TH15-06-0478","article-title":"Uncertain thrombophilia markers","volume":"115","author":"Franchini","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.acvd.2026.04.004_bib0650","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1055\/s-0042-1757562","article-title":"Markers of hereditary thrombophilia with unclear significance","volume":"42","author":"Sachs","year":"2022","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.acvd.2026.04.004_bib0655","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20200860","article-title":"Meta-analysis of the relationship between methylenetetrahydrofolate reductase C677T and A1298C polymorphism and venous thromboembolism in the Caucasian and Asian","volume":"40","author":"Gao","year":"2020","journal-title":"Biosci Rep"},{"key":"10.1016\/j.acvd.2026.04.004_bib0660","doi-asserted-by":"crossref","first-page":"I9","DOI":"10.1161\/01.CIR.0000078469.07362.E6","article-title":"Risk factors for venous thromboembolism","volume":"107","author":"Anderson","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2026.04.004_bib0665","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1538-7836.2005.01141.x","article-title":"Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies","volume":"3","author":"Den Heijer","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.acvd.2026.04.004_bib0670","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1001\/archinte.158.19.2101","article-title":"Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease","volume":"158","author":"Ray","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.acvd.2026.04.004_bib0675","first-page":"CD006612","article-title":"Homocysteine-lowering interventions for preventing cardiovascular events","volume":"8","author":"Mart\u00ed-Carvajal","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.acvd.2026.04.004_bib0680","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.jtha.2024.10.022","article-title":"An update on laboratory detection and interpretation of antiphospholipid antibodies for diagnosis of antiphospholipid syndrome: guidance from the ISTH-SSC Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibodies","volume":"23","author":"Devreese","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.acvd.2026.04.004_bib0685","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1538-7836.2009.03674.x","article-title":"Clinical course of high-risk patients diagnosed with antiphospholipid syndrome","volume":"8","author":"Pengo","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.acvd.2026.04.004_bib0690","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.thromres.2022.04.021","article-title":"Prevalence of aPhosphatidylserine\/prothrombin antibodies and association with antiphospholipid antibody profiles in patients with antiphospholipid syndrome: a systematic review and meta-analysis","volume":"214","author":"Zhu","year":"2022","journal-title":"Thromb Res"},{"key":"10.1016\/j.acvd.2026.04.004_bib0695","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.thromres.2022.08.012","volume":"218","author":"Vandevelde","year":"2022","journal-title":"Thromb Res"},{"key":"10.1016\/j.acvd.2026.04.004_bib0700","doi-asserted-by":"crossref","first-page":"972012","DOI":"10.3389\/fimmu.2022.972012","article-title":"Non-criteria antiphospholipid antibodies in antiphospholipid syndrome: diagnostic value added","volume":"13","author":"Liu","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.acvd.2026.04.004_bib0705","doi-asserted-by":"crossref","first-page":"7164","DOI":"10.3390\/jcm14207164","article-title":"IgM Antiphospholipid antibodies in antiphospholipid syndrome: prevalence, clinical associations, and diagnostic implications-a scoping review","volume":"14","author":"O\u010dkov\u00e1","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.acvd.2026.04.004_bib0710","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.revmed.2022.04.031","article-title":"[Contribution of antiphosphatidylserine\/prothrombin (anti-PS\/PT) antibody detection in the diagnosis and management of antiphospholipid syndrome (APS)]","volume":"43","author":"Delarue","year":"2022","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.acvd.2026.04.004_bib0715","doi-asserted-by":"crossref","first-page":"e70122","DOI":"10.1002\/acr2.70122","article-title":"IgG and IgM Anti-phosphatidylserine\/prothrombin complex antibody detection may improve classification accuracy of systemic lupus erythematosus and antiphospholipid antibody syndrome","volume":"7","author":"Donath","year":"2025","journal-title":"ACR Open Rheumatol"},{"key":"10.1016\/j.acvd.2026.04.004_bib0720","article-title":"Usefulness and limits of DOAC removal agents based on activated charcoal in thrombophilia testing: literature review and expert proposals","author":"Jourdi","year":"2025","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.acvd.2026.04.004_bib0725","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1111\/jth.14846","article-title":"Lupus anticoagulant detection in anticoagulated patients. Guidance from the Scientific and Standardization Committee for lupus anticoagulant\/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis","volume":"18","author":"Tripodi","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.acvd.2026.04.004_bib0730","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","article-title":"American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism","volume":"4","author":"Ortel","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.acvd.2026.04.004_bib0735","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1016\/j.jtha.2024.08.006","article-title":"The use of direct oral anticoagulants in the secondary prevention of venous thromboembolism in patients with severe thrombophilia: communication from the ISTH SSC Subcommittee on Physiological Anticoagulants and Thrombophilia","volume":"22","author":"Kovac","year":"2024","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.acvd.2026.04.004_bib0740","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1056\/NEJMoa1700518","article-title":"Rivaroxaban or aspirin for extended treatment of venous thromboembolism","volume":"376","author":"Weitz","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2026.04.004_bib0745","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1207541","article-title":"Apixaban for extended treatment of venous thromboembolism","volume":"368","author":"Agnelli","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2026.04.004_bib0750","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1055\/s-0042-1749590","article-title":"Antiphospholipid syndrome in patients with venous thromboembolism","volume":"49","author":"Pengo","year":"2023","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.acvd.2026.04.004_bib0755","article-title":"Pregnancy, thrombophilia, and the risk of a first venous thrombosis: systematic review and bayesian meta-analysis","volume":"359","author":"Croles","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.acvd.2026.04.004_bib0760","doi-asserted-by":"crossref","first-page":"e320","DOI":"10.1016\/S2352-3026(20)30007-7","article-title":"Risk of pregnancy-related venous thromboembolism and obstetrical complications in women with inherited type I antithrombin deficiency: a retrospective, single-centre, cohort study","volume":"7","author":"Abbattista","year":"2020","journal-title":"Lancet Haematol"},{"issue":"5","key":"10.1016\/j.acvd.2026.04.004_bib0765","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1055\/a-2650-7959","article-title":"How to manage venous thromboembolism risk during pregnancy in patients with inherited antithrombin deficiency?","volume":"126","author":"Mauge","year":"2026","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.acvd.2026.04.004_bib0770","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/S0140-6736(22)02128-6","article-title":"Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial","volume":"400","author":"Bistervels","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.acvd.2026.04.004_bib0775","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1080\/13697137.2025.2503874","article-title":"Safety of menopause hormone therapy in postmenopausal women at higher risk of venous thromboembolism: a systematic review","volume":"28","author":"Hicks","year":"2025","journal-title":"Climacteric"},{"key":"10.1016\/j.acvd.2026.04.004_bib0780","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/GME.0000000000001938","article-title":"Transdermal estrogen therapy in menopausal women at increased risk for thrombotic events: a scoping review","volume":"29","author":"Sobel","year":"2022","journal-title":"Menopause"},{"key":"10.1016\/j.acvd.2026.04.004_bib0785","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/20533691221148036","article-title":"Hormone replacement therapy in women with history of thrombosis or a thrombophilia","volume":"29","author":"Morris","year":"2023","journal-title":"Post Reprod Health"},{"key":"10.1016\/j.acvd.2026.04.004_bib0790","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/ajh.27222","article-title":"Inherited thrombophilia gene mutations and risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis","volume":"99","author":"Roy","year":"2024","journal-title":"Am J Hematol"},{"key":"10.1016\/j.acvd.2026.04.004_bib0795","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s11239-020-02180-x","article-title":"Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE","volume":"50","author":"Weitz","year":"2020","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.acvd.2026.04.004_bib0800","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1182\/bloodadvances.2020003442","article-title":"American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer","volume":"5","author":"Lyman","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.acvd.2026.04.004_bib0805","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/CCO.0000000000001125","article-title":"Cancer-associated thrombosis: what is new?","volume":"37","author":"Mah\u00e9","year":"2025","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.acvd.2026.04.004_bib0810","doi-asserted-by":"crossref","first-page":"2300449","DOI":"10.1183\/13993003.00449-2023","article-title":"Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: an updated systematic review and meta-analysis","volume":"62","author":"Luijten","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.acvd.2026.04.004_bib0815","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1161\/CIRCULATIONAHA.110.015008","article-title":"Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry","volume":"124","author":"Pepke-Zaba","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2026.04.004_bib0820","doi-asserted-by":"crossref","first-page":"2002828","DOI":"10.1183\/13993003.02828-2020","article-title":"ERS statement on chronic thromboembolic pulmonary hypertension","volume":"57","author":"Delcroix","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.acvd.2026.04.004_bib0825","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jacasi.2022.02.010","article-title":"Prevalence, genetic background, and clinical phenotype of congenital\u00a0thrombophilia in chronic thromboembolic pulmonary hypertension","volume":"2","author":"Lian","year":"2022","journal-title":"JACC Asia"},{"key":"10.1016\/j.acvd.2026.04.004_bib0830","doi-asserted-by":"crossref","DOI":"10.1177\/10760296241271369","article-title":"The incidence of the thrombophilic SNPs rs6025, rs1799963, rs2066865, rs2289252, and rs8176719 in chronic thromboembolic pulmonary hypertension","volume":"30","author":"Kvasni\u010dka","year":"2024","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.acvd.2026.04.004_bib0835","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2023.01.012","article-title":"Antiphospholipid antibodies in chronic thromboembolic pulmonary hypertension","volume":"111","author":"Zhu","year":"2023","journal-title":"Eur J Int Med"},{"key":"10.1016\/j.acvd.2026.04.004_bib0840","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1177\/0961203318810427","article-title":"Pulmonary thromboendarterectomy is a curative resolution for chronic thromboembolic pulmonary hypertension associated with antiphospholipid syndrome: a retrospective cohort study","volume":"27","author":"Li","year":"2018","journal-title":"Lupus"}],"container-title":["Archives of Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213626002056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213626002056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T11:38:09Z","timestamp":1787657889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875213626002056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":84,"journal-issue":{"issue":"8-9","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1875213626002056"],"URL":"https:\/\/doi.org\/10.1016\/j.acvd.2026.04.004","relation":{},"ISSN":["1875-2136"],"issn-type":[{"value":"1875-2136","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombophilia testing in venous thromboembolism: When, who and why it matters. A practical review","name":"articletitle","label":"Article Title"},{"value":"Archives of Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acvd.2026.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}